TRP Natural Eyes Pink Eye Relief Eye Drops Recalled for Sterility Concerns
TRP Natural Eyes Pink Eye Relief sterile eye drops are being recalled due to lack of assurance of sterility. The recall affects 139,656 bottles distributed nationwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall of a sterile ophthalmic product due to lack of assurance of sterility. No illnesses or injuries have been reported, but the product presents a risk of harm if not sterile, fitting the High category for risk-of-harm products without reported injury.
Plain-English summary
Optikem International, Inc. is recalling TRP Natural Eyes Pink Eye Relief sterile eye drops (homeopathic, 0.33 FL OZ / 10 mL bottles) due to lack of assurance of sterility. The recalled product includes lots P516 through P526 with expiration dates ranging from March 2024 through June 2026.
The product has been distributed nationwide in the USA. Affected consumers should stop using the product and may contact the manufacturer or their healthcare provider with questions.
The recalled product
- Product
- TRP Natural Eyes Pink Eye Relief, Sterile Eye Drops, Homeopathic, 0.33 FL OZ (10 mL), Manufactured for TRP Company, Inc, 1575 Delucchi Lane, Suite # 208, Reno, NV, NDC # 17312-013-15.
- Manufacturer
- Optikem International, Inc.
- Category
- Drug — Ophthalmic
- Hazard
- lack-of-sterility
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot #: P516
- Exp: 03-24-2024
- P517
- Exp: 08-31-2024
- P518
- Exp:10-20-2024
- P519
- Exp: 03-09-2025
- P520
- Exp: 10-19-2025
- P521
- Exp: 11-09-2025
- P522
- Exp: 11-16-2025
- P523
- Exp: 01-18-2026
- P524
- Exp: 04-26-2026
- P525
- Exp: 05-10-2026
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModeratePovi-One Povidone-Iodine 10% Topical Drug Recall for Sub Potency
FDA (Drugs) · 2026-07-01
- ModerateSensipar cinacalcet hydrochloride tablets recalled for CGMP deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar Cinacalcet Tablets Recalled Due to CGMP Deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar (Cinacalcet Hydrochloride) Tablets Recalled for CGMP Deviations
FDA (Drugs) · 2026-07-01